Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Medroxyprogesterone Acetate 3semaglutide 1pazopanib 1palbociclib 1olaparib 1lenvatinib 1fluciclovine F-18 1ferrous gluconate 1dostarlimab 1Watchful Waiting 1Sunitinib 1Specimen Handling 1Resistance Training 1Progestins 1Observation 1Nutrition Assessment 1Metformin 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1LY 353381 1Indocyanine Green 1Hysteroscopy 1High-Energy Shock Waves 1Estrogen Replacement Therapy 1Biomarkers 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Endometrial Neoplasms × Resistance Training × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡